Waltham, MA, United States of America

Keisuke Kuida

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Keisuke Kuida: Innovator in Cancer Treatment

Introduction

Keisuke Kuida is a prominent inventor based in Waltham, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 3 patents to his name, Kuida is recognized for his work in advancing medical therapies.

Latest Patents

Among his latest patents, Kuida has developed methods of treating disorders using CSF1R inhibitors. These methods focus on treating cancers and other tumors by targeting the decreased proliferation, depletion, or repolarization of tumor-associated macrophages (TAMs). His work specifically addresses disorders such as tenosynovial giant cell tumor (TGCT) and diffuse-type tenosynovial giant cell tumor (DTGCT).

Career Highlights

Keisuke Kuida is currently associated with Deciphera Pharmaceuticals, LLC, where he continues to push the boundaries of cancer research. His dedication to improving treatment options for patients has made him a valuable asset in the pharmaceutical industry.

Collaborations

Throughout his career, Kuida has collaborated with notable colleagues, including Daniel L Flynn and Bryan D Smith. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.

Conclusion

Keisuke Kuida's work in developing methods for cancer treatment showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…